 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
Benitec, Incorporated (Pink BNIKF): is a leading international biotechnology company listed on the Australian Stock Exchange, with research & development and clinical operations centered in the Silicon Valley in California, USA. Benitec was founded in 1997 to commercialize research from Queensland's Department of Primary Industries (DPI). Benitec is one of the pioneers of RNA interference (RNAi) technology, which can be used to precisely destroy RNA viruses and silence the expression of defective genes. Benitec’s core patents provide key technologies to trigger RNAi in human cells and in live animals and are jointly owned with Australia’s Commonwealth Scientific and Industrial Research Organization (CSIRO). Benitec holds exclusive worldwide rights for development and commercialization for all human applications. Website: benitec.com | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |